Latest Growth Initiatives News

Page 11 of 165
Alkane Resources delivered 42,491 ounces gold equivalent in the June quarter, pushing full-year production to 168,337 ounces and bolstering cash and investments to $454 million.
Maxwell Dee
Maxwell Dee
8 July 2026
Nine Entertainment has locked in exclusive free-to-air and streaming rights for NRL and NRLW matches from 2028 to 2034, reinforcing its dominance in Australian sports broadcasting and promising continued audience growth.
Victor Sage
Victor Sage
7 July 2026
Botanix Pharmaceuticals has received an Intention to Grant from the European Patent Office for a patent protecting its Sofdra applicator technology, potentially extending exclusivity in Europe until 2039.
Victor Sage
Victor Sage
7 July 2026
Zoono Group has reported a 94% jump in quarterly cash receipts to NZ$975K, turning cash flow positive amid expanding commercial rollouts of its shelf-life extension technology across multiple continents.
Ada Torres
Ada Torres
7 July 2026
Netwealth has broadened its partnership with Morgan Stanley Wealth Management Australia by providing a new domestic platform for ASX equities and investments, underpinning robust FY26 fund inflows and an optimistic FY27 outlook.
Claire Turing
Claire Turing
7 July 2026
Australian Unity has secured $200 million through a private placement of wholesale debt, using part of the proceeds to buy back $51.5 million of its Series D Bonds ahead of their December 2026 maturity.
Claire Turing
Claire Turing
3 July 2026
Archer Materials has raised $7 million through a placement and launched a $3 million share purchase plan, backing its strategic partnership with IonQ to develop sovereign quantum computing in Australia.
Sophie Babbage
Sophie Babbage
3 July 2026
Genesis Minerals delivered on its FY26 gold production targets for the third consecutive year, advancing the Tower Hill project ahead of schedule and completing the Magnetic Resources acquisition.
Maxwell Dee
Maxwell Dee
3 July 2026
Telix Pharmaceuticals has gained FDA alignment to advance Part 2 of its ProstACT Global Phase 3 trial for TLX591-Tx in metastatic castration-resistant prostate cancer, setting the stage for U.S. enrolment pending regulatory approval.
Ada Torres
Ada Torres
2 July 2026
HALO Technologies launches a convertible notes offer aiming to raise up to A$6.75 million, backing platform upgrades and expansion across Asia-Pacific and adviser networks.
Sophie Babbage
Sophie Babbage
2 July 2026
Magellan Financial Group has finalised its merger with Barrenjoey Capital Partners, forming a diversified financial services group poised to rebrand as Barrenjoey Group Limited. The combined entity appoints Brian Benari as CEO and David Gonski AC as Chairman, signalling a strategic expansion across investment management, financial markets, and corporate finance.
Claire Turing
Claire Turing
1 July 2026
Biome Australia has posted a 30% increase in FY26 sales revenue to $23.9 million, driven by strong domestic demand and strategic moves into onshore manufacturing and international markets.
Ada Torres
Ada Torres
1 July 2026

Browse the archive

Full archive